Qu Z, Liu M, Olcese R, Karagueuzian H, Garfinkel A, Chen P
Heart Rhythm. 2022; 19(8):1369-1383.
PMID: 35364332
PMC: 11334931.
DOI: 10.1016/j.hrthm.2022.03.1224.
Zaglia T, Pianca N, Borile G, Da Broi F, Richter C, Campione M
Proc Natl Acad Sci U S A. 2015; 112(32):E4495-504.
PMID: 26204914
PMC: 4538656.
DOI: 10.1073/pnas.1509380112.
Shah M, Bhatt N, Dabhi A, Thorat P, Chudasama K, Patel J
J Clin Diagn Res. 2014; 8(1):58-61.
PMID: 24596724
PMC: 3939588.
DOI: 10.7860/JCDR/2014/6658.3769.
Oikonomidis D, Baltogiannis G, Kolettis T
J Interv Card Electrophysiol. 2010; 28(3):157-65.
PMID: 20532602
DOI: 10.1007/s10840-010-9493-5.
Clements-Jewery H, Hearse D, Curtis M
Br J Pharmacol. 2005; 145(5):551-64.
PMID: 15852034
PMC: 1576179.
DOI: 10.1038/sj.bjp.0706231.
Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart.
Clements-Jewery H, Hearse D, Curtis M
Br J Pharmacol. 2002; 135(3):807-15.
PMID: 11834629
PMC: 1573173.
DOI: 10.1038/sj.bjp.0704509.
Pharmacological importance of stereochemical resolution of enantiomeric drugs.
Islam M, Mahdi J, Bowen I
Drug Saf. 1997; 17(3):149-65.
PMID: 9306051
DOI: 10.2165/00002018-199717030-00002.
Selective IK blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts.
Rees S, Curtis M
Br J Pharmacol. 1993; 108(1):139-45.
PMID: 8428204
PMC: 1907696.
DOI: 10.1111/j.1476-5381.1993.tb13453.x.
Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial.
Pipilis A, Flather M, Collins R, Hargreaves A, Kolettis T, Boon N
Br Heart J. 1993; 69(2):161-5.
PMID: 7679583
PMC: 1024944.
DOI: 10.1136/hrt.69.2.161.
Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
Roberts C, Marshall A, Jordan S, Barritt D, Goodfellow R
Br J Clin Pharmacol. 1984; 18(5):725-32.
PMID: 6439233
PMC: 1463540.
DOI: 10.1111/j.1365-2125.1984.tb02535.x.
Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine.
Kertes P, Hunt D
Br Heart J. 1984; 52(3):241-7.
PMID: 6380549
PMC: 481620.
DOI: 10.1136/hrt.52.3.241.
Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.
Rossi P, Yusuf S, Ramsdale D, Furze L, Sleight P
Br Med J (Clin Res Ed). 1983; 286(6364):506-10.
PMID: 6186329
PMC: 1546543.
DOI: 10.1136/bmj.286.6364.506.
Early intravenous beta-blockade in myocardial infarction.
Sleight P, Yusuf S, Ramsdale D, Rossi P, Peto R, Bennett D
Br J Clin Pharmacol. 1982; 14 Suppl 1:37S-43S.
PMID: 6126207
PMC: 1427471.
DOI: 10.1111/j.1365-2125.1982.tb02057.x.
The history of coronary care units.
Julian D
Br Heart J. 1987; 57(6):497-502.
PMID: 3304366
PMC: 1277217.
DOI: 10.1136/hrt.57.6.497.
Assessment of the risk-benefit ratio for antiarrhythmic drug use.
CAMPBELL R
Drugs. 1988; 36(5):616-32.
PMID: 3063500
DOI: 10.2165/00003495-198836050-00005.
Torsades de pointes: arrhythmia, syndrome, or chimera? A perspective in the light of the Lambeth Conventions.
Curtis M
Cardiovasc Drugs Ther. 1991; 5(1):191-200.
PMID: 2036339
DOI: 10.1007/BF03029820.
Ventricular arrhythmias during treatment with alteplase (recombinant tissue plasminogen activator) in suspected acute myocardial infarction.
Wilcox R, Eastgate J, Harrison E, Skene A
Br Heart J. 1991; 65(1):4-8.
PMID: 1899582
PMC: 1024453.
DOI: 10.1136/hrt.65.1.4.